JPRN-UMIN000041915Completed未知
Identification of biomarkers that predict responsiveness to Dupilumab among severe asthma - Biomarker for Dupilumab
ational Hospital Organization Tokyo National Hospital0 sites15 target enrollmentStarted: September 28, 2020Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
- Enrollment
- 15
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- 20years-old to ot applicable (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Patient whom the researchers think is not suitable for the study.
Investigators
Similar Trials
Not yet recruiting
Not Applicable
Identifying factors that help predict improvement with deep brain stimulation (a surgical treatment) for obsessive-compulsive disorderCTRI/2020/03/024131Wellcome Trust DBT India Alliance
Active, not recruiting
Phase 1
prediction of response to therapy in inflammatory bowel diseaseEUCTR2018-002925-47-ESFundación de Investigación Biomédica del Hospital Universitario de La Princesa180
Recruiting
Not Applicable
Biomarker studies for potentially predicting response to nivolumab in patients with unresectable or recurrent non-small cell lung cancerunresectable or recurrent non-small cell lung cancerJPRN-UMIN000026040Kagoshima University90
Completed
Not Applicable
Exploratory study of biomarkers predicting response to nivolumab in non-small-cell lung canceron-small-cell lung cancerJPRN-UMIN000022505Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine200
Recruiting
Not Applicable
Development of biomarker predicting the response of immunotherapy for patients with urothelial cancer using urine miRNAurothelial cancerJPRN-UMIN000047198Tokyo Medical University120